Form 4 for CDNA CareDx, Inc.
Accepted 2022-01-06 00:00:00 ET · period of report 2022-01-05 · accession 0001217234-22-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-01-06 | 2022-01-05 | CDNA | Maag Peter | Dir | S - Sale+OE | $44.45 | -10.0K | 341.8K | -3% | -$444.5K |
| DM | 2022-01-06 | 2022-01-05 | CDNA | Maag Peter | Dir | M - OptEx | $24.30 | +10.0K | 342.7K | +3% | +$243.0K |
| DM | 2022-01-06 | 2022-01-05 | CDNA | Maag Peter | Dir | M - OptEx | $0.00 | -10.0K | 61.2K | -14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-05 | S | D | 8,146 | $44.29 | 343,610 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.85 to $44.80, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. |
| 2 | Common | Common Stock | 2022-01-05 | M | A | 5,735 | $27.17 | 351,756 | D | — | — | |
| 3 | Common | Common Stock | 2022-01-05 | M | A | 3,340 | $24.35 | 346,021 | D | — | — | |
| 4 | Common | Common Stock | 2022-01-05 | S | D | 1,854 | $45.13 | 341,756 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45 to $45.29, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. |
| 5 | Common | Common Stock | 2022-01-05 | M | A | 925 | $6.31 | 342,681 | D | — | — | |
| 6 | Derivative | Employee Stock Option (right to buy) | 2022-01-05 | M | D | 3,340 | $0.00 | 41,667 | D | $24.35 · — to 2030-02-03 | 3,340 Common Stock | (F6) 1/4th of the shares subject to the option vested on January 29, 2021 and 1/48th of the shares subject to the option vest monthly thereafter. |
| 7 | Derivative | Employee Stock Option (right to buy) | 2022-01-05 | M | D | 925 | $0.00 | 6,165 | D | $6.31 · — to 2028-01-19 | 925 Common Stock | (F5) 1/4th of the shares subject to the option shall vested January 19, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. |
| 8 | Derivative | Employee Stock Option (right to buy) | 2022-01-05 | M | D | 5,735 | $0.00 | 61,164 | D | $27.17 · — to 2029-02-04 | 5,735 Common Stock | (F7) 1/4th of the shares subject to the option vested on January 25, 2020 and 1/48th of the shares subject to the option vest monthly thereafter. |